Methyl 3-hydroxy-4-methylbenzoate

CAS : 3556-86-3

Ref. 3D-FM38416

Informations sur le produit

• Nom: Methyl 3-hydroxy-4-methylbenzoate
• Marque: Biosynth
• Description: Methyl 3-hydroxy-4-methylbenzoate (HMBA) is a metabolite of the anti-cancer drug methotrexate. HMBA has shown an inhibitory effect on acid phosphatase and on the growth of cancer cells. It also has an anti-inflammatory effect, which may be due to its ability to inhibit enzyme extracts from inflammatory diseases such as arthritis or asthma. HMBA has been shown to have a pharmacokinetic profile in vivo, which has been demonstrated by using SW620 cells. This compound is also able to cross the blood brain barrier and accumulate in cancerous tumors.

Propriétés chimiques

• Masse moléculaire: 166.17 g/mol
• Formule: C₉H₁₀O₃
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C9H10O3/c1-6-3-4-7(5-8(6)10)9(11)12-2/h3-5,10H,1-2H3
• Code InChI: InChIKey=GCSINTLJUNXLLU-UHFFFAOYSA-N
• SMILES: COC(=O)c1ccc(C)c(O)c1